The latent inhibition model of schizophrenia: Further validation using the atypical neuroleptic, clozapine

Ina Weiner*, Eran Shadach, Ricardo Tarrasch, Rachel Kidron, Joram Feldon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'The latent inhibition model of schizophrenia: Further validation using the atypical neuroleptic, clozapine'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science